TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36435148

Group type: EXPERIMENTAL
Intervention: Mirror Exposure (ME)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Wait-list Control Group (WCG)
Number of subjects: 76
Study: 34656876

Group type: EXPERIMENTAL
Intervention: Aviandr 40 mg daily
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Aviandr 60 mg daily
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Aviandr (both doses)
Number of subjects: 129
Study: 32375499

Group type: EXPERIMENTAL
Intervention: Low biosecurity measures
Number of subjects: 13

Group type: COMPARATOR
Intervention: Higher biosecurity levels and proper management
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Implementation of basic biosecurity measures
Number of subjects: 13
Study: 35650583

Group type: EXPERIMENTAL
Intervention: Home gardening and nutrition counseling intervention (bio-diversification of horticultural home gardens and nutritional health counseling using WHO's 7 Essential Nutrition Action messages)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Home gardening and nutrition counseling intervention
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 1200
Study: 33325010

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 15
Study: 34783456

Group type: EXPERIMENTAL
Intervention: Generic budesonide nasal spray (256 μg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Branded budesonide nasal spray (256 μg)
Number of subjects: 32
Study: 34074263

Group type: EXPERIMENTAL
Intervention: Randomized test‐treatment studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample size re‐estimation based on a nuisance parameter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive designs within randomized test‐treatment studies
Number of subjects: 0
Study: 34806941

Group type: EXPERIMENTAL
Intervention: Student-led (autonomous) HIIT condition
Number of subjects: 402

Group type: COMPARATOR
Intervention: Teacher-led (non-autonomous) HIIT condition
Number of subjects: 402
Study: 35562781

Group type: EXPERIMENTAL
Intervention: Financial navigation intervention (brief: one cycle, Arm 2; extended: three cycles, Arm 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced usual care (comparison group, Arm 1)
Number of subjects: 0
Study: 32394880

Group type: EXPERIMENTAL
Intervention: V180 nonadjuvanted (N = 8)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: V180 adjuvanted with Alhydrogel™ (N = 8)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (N = 4)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: V180 vaccine
Number of subjects: 20
Study: 35049505

Group type: EXPERIMENTAL
Intervention: SMART4MD
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: TV-AssistDem
Number of subjects: 151

Group type: COMPARATOR
Intervention: Living alone
Number of subjects: 151

Group type: COMPARATOR
Intervention: Technophilia
Number of subjects: 151

Group type: COMPARATOR
Intervention: ICTs (television and smartphone)
Number of subjects: 151
Study: 33671260

Group type: EXPERIMENTAL
Intervention: Toxins + HP
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Toxins + XL
Number of subjects: 360

Group type: COMPARATOR
Intervention: Toxins
Number of subjects: 360
Study: 32492377

Group type: EXPERIMENTAL
Intervention: CSP with submucosal injection (CSP-SI)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conventional cold snare polypectomy (C-CSP)
Number of subjects: 214
Study: 33026895

Group type: EXPERIMENTAL
Intervention: AOT plus BCI-FES
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (FES treatment and conventional physical therapy)
Number of subjects: 26
Study: 34966761

Group type: EXPERIMENTAL
Intervention: DEX + AZA
Number of subjects: 172

Group type: COMPARATOR
Intervention: AZA
Number of subjects: 172
Study: 34979180

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (n = 318)
Number of subjects: 642

Group type: COMPARATOR
Intervention: Control group (n = 324)
Number of subjects: 642
Study: 34311135

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei rhamnosus (LGG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33027431

Group type: EXPERIMENTAL
Intervention: High adherence to the BALANCE Program
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: All 24-hour dietary recalls (24HR) analyzed
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: Lowest tertile of adherence
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: Healthy versus unhealthy foods
Number of subjects: 1160
Study: 36107590

Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES) for 20 minutes on the day before and on the morning of surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midazolam (0.07 mg/kg) intramuscularly injected 30 minutes before general anesthesia
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midazolam (0.07 mg/kg)
Number of subjects: 80
Study: 32971314

Group type: EXPERIMENTAL
Intervention: Continuation cognitive therapy (CT)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 290

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Acute-phase cognitive therapy (CT)
Number of subjects: 290
Study: 32967726

Group type: EXPERIMENTAL
Intervention: Electrolyte supplementation (Magnesium, Calcium, and Potassium) with intravenous normal saline
Number of subjects: 99

Group type: COMPARATOR
Intervention: Normal saline alone (control group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Electrolyte supplementation
Number of subjects: 99
Study: 36263238

Group type: EXPERIMENTAL
Intervention: Rocuronium intubation dosages based on Lean Body Weight (LBW) in Group 1 LBW
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group receiving 0.6 mg/kg rocuronium based on Total Body Weight (TBW) in Group 1K
Number of subjects: 3
Study: 33137547

Group type: EXPERIMENTAL
Intervention: QUiPP app intervention (decision and communication tool)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control (normal practice)
Number of subjects: 202
Study: 35570929

Group type: EXPERIMENTAL
Intervention: Avelumab maintenance therapy (AVE group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care (CON group)
Number of subjects: 0
Study: 35074637

Group type: EXPERIMENTAL
Intervention: Smoking discarded cigarettes
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Younger smokers, men, smokers with lower incomes, and those who were not employed
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Unmet social needs (transportation, food, housing, physical safety, neighborhood safety)
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Living with other smokers
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Worse mental health
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Greater perceived stress
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Heavier smoking
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Using other tobacco products
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Bumming cigarettes from others
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Income, social environment, and other smoking behaviors
Number of subjects: 1936
Study: 32828934

Group type: EXPERIMENTAL
Intervention: 5-strand hamstring grafts
Number of subjects: 64

Group type: COMPARATOR
Intervention: 4-strand hamstring grafts
Number of subjects: 64
Study: 33748529

Group type: EXPERIMENTAL
Intervention: Stochastic vibrotactile stimulation (SVS) mattress: specially‐constructed SVS crib mattress that delivers gentle vibrations (30–60 Hz, 12 μm RMS surface displacement) at 3‐hr intervals
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control mattress (treatment as usual; TAU): non‐oscillating hospital‐crib mattress
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Stochastic vibrotactile stimulation (SVS) mattress
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control mattress (treatment as usual; TAU)
Number of subjects: 230
Study: 32326956

Group type: EXPERIMENTAL
Intervention: Proactive support of labour with one-to-one midwife support, amniotomy and/or oxytocin stimulation if no progression during the next 1-2 hours.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard support of labour following standard procedures: Expectance until established regular contractions and 4-5 cm cervical dilatation, then one-to-one midwife support.
Number of subjects: 0
Study: 33992072

Group type: EXPERIMENTAL
Intervention: Strategies for promoting physical activity (mother’s physical activity groups, home‐based physical activity programs, awareness‐raising)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Strategies to reduce screen time (screen time tracker apps, increasing social connections, awareness‐raising)
Number of subjects: 20
Study: 32595082

Group type: EXPERIMENTAL
Intervention: Antipsychotic polypharmacy (two or more co-prescribed antipsychotic drugs)
Number of subjects: 24239

Group type: COMPARATOR
Intervention: Antipsychotic monotherapy
Number of subjects: 24239
Study: 35793815

Group type: COMPARATOR
Intervention: Intra-aortic balloon pump
Number of subjects: 0

Group type: COMPARATOR
Intervention: TandemHeart and Impella devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venoarterial extracorporeal membrane oxygenation
Number of subjects: 0
Study: 33706831

Group type: EXPERIMENTAL
Intervention: Dietary diversity scores (DDS) at 6-8 months
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Not ill at 6-8 months
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Maternal/caregiver nutritional education intervention
Number of subjects: 385
Study: 32768394

Group type: EXPERIMENTAL
Intervention: Aerobic training with whole-body vibration (WBV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerobic training without whole-body vibration (WBV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (aerobic training with and without WBV)
Number of subjects: 0
Study: 35253776

Group type: EXPERIMENTAL
Intervention: Structured Medication Review (SMR)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 202
Study: 33412562

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Antidepressant Medication Management (MEDS)
Number of subjects: 300
Study: 35606223

Group type: EXPERIMENTAL
Intervention: Standard Intervention (SI)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Group Intervention (GI)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Individual Intervention (II)
Number of subjects: 70
Study: 33092897

Group type: EXPERIMENTAL
Intervention: Wii training in addition to traditional therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 30
Study: 34582775

Group type: EXPERIMENTAL
Intervention: Invasive management
Number of subjects: 388

Group type: COMPARATOR
Intervention: Moderate ischemia (reference)
Number of subjects: 388
Study: 36126144

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 34792482

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloon (DCB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 120
Study: 33492254

Group type: EXPERIMENTAL
Intervention: Two suture anchors for refixation
Number of subjects: 31

Group type: COMPARATOR
Intervention: One suture anchor for refixation
Number of subjects: 31
Study: 33109663

Group type: EXPERIMENTAL
Intervention: Iodinated oil injection (OSCM group, oil-soluble contrast media)
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Ioversol injection (WSCM group, water-soluble contrast media)
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Iodinated oil injection (OSCM group)
Number of subjects: 1040
Study: 35215501

Group type: EXPERIMENTAL
Intervention: Nutritional supplements based on L-Theanine and Vitamin B6
Number of subjects: 34

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 34
Study: 34216833

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking after meals
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 3
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control period (no exercise)
Number of subjects: 14
Study: 34087745

Group type: EXPERIMENTAL
Intervention: Quetiapine (QTP)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Dronabinol (DRO)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Lofexidine + Dronabinol (LFD)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 391
Study: 33290307

Group type: EXPERIMENTAL
Intervention: Saccadic Vector Optokinetic Perimetry (SVOP)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard Automated Perimetry (SAP)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Age-related sensitivity decrease
Number of subjects: 97
Study: 36429975

Group type: EXPERIMENTAL
Intervention: Multi-modal strength intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multi-modal flexibility intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multi-modal flexibility intervention (females)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multi-modal flexibility intervention (males)
Number of subjects: 40
Study: 35073989

Group type: EXPERIMENTAL
Intervention: 1 + 1 schedule (one dose at 6 weeks and a booster at 9 months)
Number of subjects: 68

Group type: COMPARATOR
Intervention: 3 + 0 schedule (three doses at 6, 10, and 14 weeks)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 1 + 1 schedule
Number of subjects: 68
Study: 35977025

Group type: EXPERIMENTAL
Intervention: AMY-101
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33783399

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin 36 IU (3 sprays) twice a day
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intranasal placebo-oxytocin (3 sprays) twice a day
Number of subjects: 62
Study: 32750332

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) nasal spray
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (PL) nasal spray
Number of subjects: 94
Study: 36399342

Group type: EXPERIMENTAL
Intervention: Standard message group
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Tailored message group
Number of subjects: 945

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 945
Study: 32162943

Group type: EXPERIMENTAL
Intervention: 2-week intervention designed to increase relationship maintenance in marriage
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Greater relationship maintenance from spouses
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Greater relationship maintenance for wives
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Greater relationship maintenance for fathers
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2-week intervention
Number of subjects: 60
Study: 34841461

Group type: EXPERIMENTAL
Intervention: Supervised high‐intensity interval training during NACRT followed by unsupervised continuous exercise after NACRT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 34444881

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GF) with varying sucrose concentrations
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Vegetable broth (VB) with varying sodium chloride concentrations
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Food choice, familiarity, stated liking, and neophobia questionnaires
Number of subjects: 148
Study: 32926462

Group type: EXPERIMENTAL
Intervention: Baricitinib (2 mg)
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Baricitinib (4 mg)
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Baricitinib (all doses)
Number of subjects: 2531

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531
Study: 32209490

Group type: EXPERIMENTAL
Intervention: Peer-led learning group (n = 34)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mentorship-led group (n = 34)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Faculty-led control group (n = 34)
Number of subjects: 102
Study: 33057858

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32203810

Group type: EXPERIMENTAL
Intervention: Negative air ions (NAI)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Particulate matter (PM) reduction
Number of subjects: 44
Study: 36370636

Group type: EXPERIMENTAL
Intervention: Tampax Menstrual Cup
Number of subjects: 65

Group type: COMPARATOR
Intervention: Another menstrual cup
Number of subjects: 65
Study: 32930621

Group type: EXPERIMENTAL
Intervention: Brief self-exercise education (brief-See)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Material-based education alone
Number of subjects: 0
Study: 32586302

Group type: EXPERIMENTAL
Intervention: Caries-free children (case group)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Children with dental caries (control group)
Number of subjects: 500
Study: 36069322

Group type: EXPERIMENTAL
Intervention: Telemedicine follow-up
Number of subjects: 123

Group type: COMPARATOR
Intervention: Face-to-face follow-up
Number of subjects: 123
Study: 33872417

Group type: EXPERIMENTAL
Intervention: Family Nurse Practitioner-led training programme (1-hour training session on self-measurement of blood pressure)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Usual care (written and verbal information on HBPM recommendations)
Number of subjects: 170
Study: 35943120

Group type: EXPERIMENTAL
Intervention: Ranger drug‐coated balloon (DCB)
Number of subjects: 129
Study: 34032934

Group type: EXPERIMENTAL
Intervention: Personalized pharmaceutical plan with a 30-min opioid-targeted pharmaceutical interview
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study: 35538479

Group type: EXPERIMENTAL
Intervention: E2/NOMAC (1.5 mg 17β-estradiol + 2.5 mg nomegestrol acetate)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: DNG (2 mg/daily dienogest)
Number of subjects: 197
Study: 32101302

Group type: EXPERIMENTAL
Intervention: Skin Self-monitoring (SSM) smartphone application with monthly self-monitoring reminders
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard written advice on sun protection and skin cancer detection
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Skin Self-monitoring (SSM) smartphone application
Number of subjects: 238
Study: 35043716

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus Aspirin 100 mg once daily
Number of subjects: 88

Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 88
Study: 32114641

Group type: EXPERIMENTAL
Intervention: High polyphenols (PP) diet
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High long-chain n-3 polyunsaturated fatty acids (LCn3) diet
Number of subjects: 78

Group type: COMPARATOR
Intervention: Low LCn3 and PP diet
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High LCn3 and PP diet
Number of subjects: 78
Study: 36028272

Group type: EXPERIMENTAL
Intervention: Community influencer groups intervention
Number of subjects: 632

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 632
Study: 34762673

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid training, mental health awareness session, confidential staff peer support service
Number of subjects: 1722

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 1722
Study: 33720967

Group type: EXPERIMENTAL
Intervention: Children who smoke
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Women with a role as a family member
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Women who use alcohol
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Women living in a family with financial problems
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Women living with a family member who uses alcohol
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Elderly who use alcohol
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Elderly living with a family member who uses alcohol
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Elderly living in a family with financial problems
Number of subjects: 646
Study: 32739072

Group type: EXPERIMENTAL
Intervention: Oral hygiene program combined with home-phone health promoting counseling
Number of subjects: 136
Study: 35148643

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCl)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline solution (NSS)
Number of subjects: 16
Study: 32889038

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with Lavender essential oil
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with Citrus Aurantium essential oil
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (foot massage)
Number of subjects: 105
Study: 33877646

Group type: EXPERIMENTAL
Intervention: 8-week classroom education and mindfulness-based physical activity intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 110
Study: 33478383

Group type: EXPERIMENTAL
Intervention: PgNACs under salinity stress
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: PgNACs under drought stress
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: PgNACs examined by quantitative reverse transcription‐PCR
Number of subjects: 151
Study: 32843075

Group type: EXPERIMENTAL
Intervention: Intermittent enteral feeding with a high-protein formula
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous enteral feeding with a high-protein formula
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intermittent enteral feeding
Number of subjects: 60